Top Markets
Coin of the day
Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS
Rankning i aktier #33550
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
Aktiekurs
$0.11989842
Marknadsvärde
$7.42M
Förändring (1 dag)
6.25%
Förändring (1 år)
179.27%
Land
AU
Handel Vectus Biosystems Limited (VBS)

Kategori

Historik för aktiesplit för Vectus Biosystems Limited (VBS)
Aktien Vectus Biosystems Limited (symbol: VBS) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 17, 2026.
En VBS-aktie köpt före Aug 17, 2026 motsvarar nu 0 VBS-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE